Detalhe da pesquisa
1.
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.
Blood
; 143(17): 1726-1737, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38241630
2.
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Blood
; 143(13): 1231-1241, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145560
3.
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
Blood
; 139(17): 2706-2711, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134127
4.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Blood
; 140(1): 16-24, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325065
5.
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
Mol Ther
; 31(1): 24-34, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36086817
6.
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
Br J Haematol
; 200(1): 54-63, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36120837
7.
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Blood
; 137(19): 2585-2597, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270816
8.
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
Haematologica
; 108(7): 1840-1850, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373249
9.
COVID-specific T's may offset therapeutically endangered B's.
Blood
; 139(1): 12-13, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989773
10.
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.
Clin Adv Hematol Oncol
; 16(5): 375-386, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29851933
11.
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas.
Hematol Oncol Clin North Am
; 37(6): 1107-1124, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357070
12.
Beyond CD19 CAR-T cells in lymphoma.
Curr Opin Immunol
; 74: 46-52, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800921
13.
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
Bone Marrow Transplant
; 57(4): 579-585, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35105965
14.
Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.
Leuk Lymphoma
; 62(13): 3256-3263, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278937
15.
Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow Products.
Transplant Cell Ther
; 27(9): 785.e1-785.e6, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082160
16.
CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment Paradigm.
Adv Cell Gene Ther
; 2(3)2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777773
17.
New and emerging therapies for acute and chronic graft versus host disease.
Ther Adv Hematol
; 9(1): 21-46, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29317998